
1.46BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US71742Q1067
CUSIP
71742Q106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
15.42
PEG Ratio
1.68
Book Value
8.92
Dividend Share
0.48
Dividend Yield
1.34%
Earnings Share
2.34
Wall Street Target Price
45.00
EPS Estimate Current Year
3.07
EPS Estimate Next Year
3.34
EPS Estimate Current Quarter
0.726
EPS Estimate Next Quarter
0.79
Most Recent Quarter
-
Revenue TTM
1,500,043,008
Gross Profit TTM
488,617,984
EBITDA
234,754,000
Profit Margin
6.35%
Return On Assets TTM
8.40%
Return On Equity TTM
30.34%
Revenue Per Share TTM
37.003
Qtly Revenue Growth YOY
10.30%
Diluted Eps TTM
2.34
Qtly Earnings Growth YOY
15.70%
Trailing PE
15.42
Forward PE
13
Price Sales TTM
0.976
Price Book MRQ
4.0259
Enterprise Value Revenue
1
Enterprise Value EBITDA
9
223.30
1.59%32.71
0.77%20.00
0.00%37.00
0.00%36.62
0.00%158.15
-3.91%10.04
-1.28%18.02
-1.26%42.34
-1.17%37.56
-1.01%